Online car marketplace Carvana has benefited from a strong used car market in 2025. New car prices have been stable for most of the year, and used car prices have also remained steady in response. Carvana Q3 results 150,941 retail units sold, +44% Revenue +55% to $5.65 billion Net Income $263 million, +$115 million year over year Record levels of retail units sold, revenue, adjusted EBITDA, and operating income As Kelley Blue Book notes, "when new car prices rise, used car prices tend to follow." ...

CEO.CA's Inside the Boardroom: Myriad Uranium Approved for 222 Holes, Grades 60% Higher Than Historic Data at Copper MountainNovember 05, 2025 11:07 AM EST | Source: CEO.CA Technologies Ltd.Toronto, Ontario--(Newsfile Corp. - November 5, 2025) -  CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popul ...

Jones Research has re-issued its ‘Hold’ rating for Bitcoin mining giant MARA (Nasdaq: MARA), noting missed expectations for third quarter earnings as higher operating costs weighed on margins. The bitcoin miner and digital infrastructure company reported third-quarter revenue of $252.4 million, up 6% from the prior quarter and above JonesResearch’s $246.1 million estimate. However, EBITDA came in at $51.0 million, below the firm’s $83.7 million projection, as general and administrative and research expens ...

Key Takeaways Corcept reported Q3 EPS of $0.16, which missed estimates and fell from $0.41 in the prior-year quarter.CORT's revenues grew 14% year over year to $207.6 million in Q3 but missed expectations.CORT cut 2025 revenue guidance to $800-$850 million, prompting a 4.6% after-hours share drop.Corcept Therapeutics (CORT) reported third-quarter 2025 earnings of 16 cents per share, which missed the Zacks Consensus Estimate of 18 cents. The company had reported earnings of 41 cents per share in the year-ago ...

U.S. crude oil stocks rose by 5.2 million barrels amid a rebound in imports, according to the Energy Information Administration. ...

LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Avantor, Inc., (“Avantor” or the "Company") (NYSE: AVTR) investors off a class action on behalf of investors that bought securities between March 5, 2024 and October 8, 2025, inclusive (the “Class Period”). Fiserv investors have until December 29, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, ...

Core Insights - Teva Pharmaceutical reported adjusted earnings of 78 cents per share on $4.48 billion in third-quarter sales, surpassing analyst expectations of 68 cents per share and $4.38 billion in sales [1] - The company raised its sales guidance for the drug Austedo to $2.05 billion to $2.15 billion, while lowering the low end of its full-year sales outlook by $200 million to a range of $16.8 billion to $17 billion [2] - Teva's stock surged 12% in premarket trading, breaking out of a cup-with-handle base and returning to its buy zone [3] Financial Performance - Teva's third-quarter sales of $4.48 billion represent an increase from $4.33 billion in the same period last year [1] - The adjusted earnings guidance for the full year has been raised to a range of $2.55 to $2.65 per share, compared to analyst expectations of $2.61 per share [2] Stock Market Activity - Teva's stock price increased to $22.91 after the earnings report, indicating strong market performance [3] - The stock had previously dipped below its entry point but managed to return to the buy zone, which extends up to $20.98 [3]

By Jacob Gronholt-Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its blockbuster obesity drugs slows, leaving investors worried the firm is losing ground to U.S. peer Eli Lilly and copycat rivals. Novo's shares whipsawed through the day, sliding and then rising on a better-than-expected Medicare pricing deal in the U.S., before eventually falling back as its new CEO struggled to win investors over to ...

According to research from CNBC, if someone had invested $10,000 in the S&P 500 index at the beginning of 2005 and left the investment untouched, it would be worth $71,750 by the end of 2024, yielding an annual return of 10.4% over that period. However, if the person investing the money decides to buy and sell the asset, they would’ve lost out on significant returns. Learn More: How To Start Investing With Less Than $1,000 Check Out: 6 Subtly Genius Moves All Wealthy People Make With Their Money The artic ...

Core Insights - Fiserv, Inc. is currently facing significant challenges, including a substantial drop in stock price and ongoing legal issues [1][6] - A class action lawsuit has been filed against Fiserv, alleging that the company misled investors regarding its 2025 initiatives, which contributed to a 47% decline in share price [3][6] - Despite a 49% decline in stock value and a downgrade to 'Strong Sell', Fiserv continues to be a key player in the financial technology sector [5][6] Financial Performance - Fiserv's stock price has decreased by 49%, attributed to leadership turmoil and weak consumer spending [5] - The current market capitalization of Fiserv is approximately $34.66 billion [2] - The stock was trading at $64.45 with a price target set at $62, indicating a price difference of about -3.80% [2] Legal Issues - The class action lawsuit covers investors who purchased Fiserv securities between July 23, 2025, and October 29, 2025, with a deadline to join the class action set for January 5, 2026 [4] - The lawsuit claims that Fiserv's guidance was based on unrealistic assumptions, misleading investors about its financial performance projections [3][4] Competitive Landscape - Fiserv competes with other financial technology companies such as PayPal and Square, which also offer digital payment solutions [1]